MMRF Logo


Register today to receive updates on our unique approach to curing multiple myeloma
  • MMRF e-Newsletter
  • Myeloma Focus Newsletter
  • Access to Clinical Trials
  • Fundraising and Participation in Local Events
MMRC
Donate
Funding Opportunities
Now Accepting Proposals:

Grant Deadline Amount
Senior Research Award Feb 3 $ 200,000
Research Fellow Award Mar 31 $ 75,000
BIA (Biotech Investment Award) Aug 25 $ 350,000–500,000
Application materials will be available online by Wednesday, July 1, 2009

The MMRF supports innovative research efforts in the most promising areas of multiple myeloma research through several grant-making programs. The MMRF accepts applications from U.S.-based and international non-profit institutions and universities. Program guidelines and applications are available approximately 6-8 weeks prior to the submission deadline.

MMRF Research Grant Awards
Significant advances in our understanding of the pathophysiology and molecular biology involved in multiple myeloma have identified numerous putative molecular targets for therapeutic intervention. The MMRF welcomes proposals on any and all multiple myeloma related topics to the traditional Research Grant Award Programs.
  • Research Fellows Awards provide funding to researchers with less than five years experience (post graduate degree) and working under the supervision of a research sponsor. Proposals may request up to $75,000 for one year. The deadline to submit an application for the Fellows Award is March 31, 2009. Anticipated applicant notification date is early May.
  • BIA Award (formerly LEAD): The Multiple Myeloma Research Foundation (MMRF) seeks proposals for its Biotech Investment Award program (BIA). The goal of this initiative is to drive and accelerate the development of innovative and effective treatments for myeloma. This program is designed to: a) provide resources necessary for biotechnology and pharmaceutical companies to rapidly test therapeutics in multiple myeloma; and b) to foster collaboration with academic myeloma experts, as needed. BIA aims to remove barriers that limit the development of novel drugs for myeloma. This is a milestone-driven initiative. Payments will be made after successful completion of milestones as outlined in each applicant's proposal.
  • Seniors Awards Program :The Multiple Myeloma Research Foundation (MMRF) seeks proposals for the 2009 Seniors Award Program, an initiative supporting researchers with more than five years experience in blood cancer research. Applications for the MMRF 2009 Seniors Award Program are due February 3, 2009. The goal of this initiative is to accelerate the development of therapeutic approaches for myeloma.
    2009 Seniors Program Guidelines (doc)
Please check back soon for more information and application criteria for our upcoming RFPs in Innovative Trials, and Clinical Imaging.